PROMÉDICAMENTS DU MODULATEUR DU RÉCEPTEUR DE PROGESTERONE (SPRM) (11.BÊTA.,17.BÊTA.)-17-HYDROXY-11-[4-(MÉTHYLSULPHONYLE)PHENYLE]-17-(PENTAFLUOROÉTHYL)ESTRA-4,9-DIÈN-3-ONE
This invention concerns Selective Progesterone Receptor Modulators (SPRM) in a prodrug form as well as to their application in therapy. (3α,11β,17β)-11-[4-(methylsulfonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-diene-3,17-diol (Compound 1) is one of the invention prodrugs.